Polly Fu1, Karen A Matthews, Rebecca C Thurston. 1. From the 1Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA; 2Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; 3Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA; and 4Department of Psychology, University of Pittsburgh, Pittsburgh, PA.
Abstract
OBJECTIVE: Studies of vasomotor symptoms (VMS) typically measure VMS via daily diaries completed at the end of the day. VMS can also be measured via diaries completed throughout the day or via physiological monitors-modalities with lower recall demands. We examined the degree of correspondence between three VMS measurement modalities: retrospective end-of-day/morning diaries, prospective reporting, and physiological monitoring. We determined whether discrepancies between measurement modalities varied by participant characteristics. METHODS: Twenty-five African-American women and 27 white women from the Pittsburgh site of the Study of Women's Health Across the Nation who were experiencing VMS, had intact uterus and ovaries, and were free of medications affecting VMS underwent 4 days of ambulatory VMS and Actiwatch monitoring. VMS were recalled in end-of-day and morning diaries, reported prospectively during the day, and measured physiologically via a hot flash monitor. Associations between anxiety, sleep, or race/ethnicity and VMS measurement modality difference scores were examined using generalized estimating equations. RESULTS: Women underestimated the number of daytime VMS at the end of the day as compared with VMS that were prospectively reported or physiologically measured throughout the day. This pattern was particularly pronounced among African-American women (b [SE] = -3.01 [0.93], P = 0.001) and women with higher anxiety (b [SE] = -3.13 [1.53], P = 0.04). For nighttime VMS, women overestimated the number of VMS in the morning upon waking as compared with prospective measures, particularly if they had poorer sleep (higher wakening after sleep onset: b [SE] = 0.03 [0.008], P = 0.001). CONCLUSIONS: Different measurement modalities yield different VMS estimates. Negative affect, sleep, and race/ethnicity may affect the recall of VMS.
OBJECTIVE: Studies of vasomotor symptoms (VMS) typically measure VMS via daily diaries completed at the end of the day. VMS can also be measured via diaries completed throughout the day or via physiological monitors-modalities with lower recall demands. We examined the degree of correspondence between three VMS measurement modalities: retrospective end-of-day/morning diaries, prospective reporting, and physiological monitoring. We determined whether discrepancies between measurement modalities varied by participant characteristics. METHODS: Twenty-five African-American women and 27 white women from the Pittsburgh site of the Study of Women's Health Across the Nation who were experiencing VMS, had intact uterus and ovaries, and were free of medications affecting VMS underwent 4 days of ambulatory VMS and Actiwatch monitoring. VMS were recalled in end-of-day and morning diaries, reported prospectively during the day, and measured physiologically via a hot flash monitor. Associations between anxiety, sleep, or race/ethnicity and VMS measurement modality difference scores were examined using generalized estimating equations. RESULTS:Women underestimated the number of daytime VMS at the end of the day as compared with VMS that were prospectively reported or physiologically measured throughout the day. This pattern was particularly pronounced among African-American women (b [SE] = -3.01 [0.93], P = 0.001) and women with higher anxiety (b [SE] = -3.13 [1.53], P = 0.04). For nighttime VMS, women overestimated the number of VMS in the morning upon waking as compared with prospective measures, particularly if they had poorer sleep (higher wakening after sleep onset: b [SE] = 0.03 [0.008], P = 0.001). CONCLUSIONS: Different measurement modalities yield different VMS estimates. Negative affect, sleep, and race/ethnicity may affect the recall of VMS.
Authors: Howard M Kravitz; Elizabeth Avery; Maryfran Sowers; Joyce T Bromberger; Jane F Owens; Karen A Matthews; Martica Hall; Huiyong Zheng; Ellen B Gold; Daniel J Buysse Journal: Sleep Date: 2011-09-01 Impact factor: 5.849
Authors: Ellen W Freeman; Mary D Sammel; Hui Lin; Clarisa R Gracia; Shiv Kapoor; Tahmina Ferdousi Journal: Menopause Date: 2005 May-Jun Impact factor: 2.953
Authors: Rachel E Williams; Linda Kalilani; Dana Britt DiBenedetti; Xiaolei Zhou; Sheri E Fehnel; Richard V Clark Journal: Maturitas Date: 2007-10-25 Impact factor: 4.342
Authors: Janet S Carpenter; Katherine A Guthrie; Joseph C Larson; Ellen W Freeman; Hadine Joffe; Susan D Reed; Kristine E Ensrud; Andrea Z LaCroix Journal: Fertil Steril Date: 2012-04-03 Impact factor: 7.490
Authors: Ellen W Freeman; Katherine A Guthrie; Bette Caan; Barbara Sternfeld; Lee S Cohen; Hadine Joffe; Janet S Carpenter; Garnet L Anderson; Joseph C Larson; Kristine E Ensrud; Susan D Reed; Katherine M Newton; Sheryl Sherman; Mary D Sammel; Andrea Z LaCroix Journal: JAMA Date: 2011-01-19 Impact factor: 157.335
Authors: Ping G Tepper; Maria M Brooks; John F Randolph; Sybil L Crawford; Samar R El Khoudary; Ellen B Gold; Bill L Lasley; Bobby Jones; Hadine Joffe; Rachel Hess; Nancy E Avis; Sioban Harlow; Daniel S McConnell; Joyce T Bromberger; Huiyong Zheng; Kristine Ruppert; Rebecca C Thurston Journal: Menopause Date: 2016-10 Impact factor: 2.953
Authors: Rebecca C Thurston; Yuefang Chang; Emma Barinas-Mitchell; J Richard Jennings; Doug P Landsittel; Nanette Santoro; Roland von Känel; Karen A Matthews Journal: Stroke Date: 2016-11-10 Impact factor: 7.914
Authors: Rebecca C Thurston; Yuefang Chang; Emma Barinas-Mitchell; J Richard Jennings; Roland von Känel; Doug P Landsittel; Karen A Matthews Journal: Menopause Date: 2017-08 Impact factor: 3.310
Authors: Wei Zhao; Jennifer A Smith; Miao Yu; Carolyn J Crandall; Rebecca C Thurston; Michelle M Hood; Edward Ruiz-Narvaez; Patricia A Peyser; Sharon L R Kardia; Sioban D Harlow Journal: Menopause Date: 2021-04-26 Impact factor: 3.310
Authors: Dahima Cintron; Brian D Lahr; Kent R Bailey; Nanette Santoro; Robin Lloyd; JoAnn E Manson; Genevieve Neal-Perry; Lubna Pal; Hugh S Taylor; Whitney Wharton; Fredrick Naftolin; S Mitchell Harman; Virginia M Miller Journal: Menopause Date: 2018-02 Impact factor: 2.953